BRCA2 and breast carcinoma: To estimate more precisely the shape of the incidence curves for BRCA1 and BRCA2 mutation carriers, we fitted a model where separate breast cancer relative risks were assumed for ages 20–39, 40–49, 50–59 and 60–79 years, for both BRCA1 and BRCA2 mutation carriers.